ITMCTR2100005417
Not yet recruiting
Phase 1
A multicenter randomized controlled clinical study of Yinlai Decoction in the treatment of children with influenza (pulmonary and gastric heat accumulation syndrome)
Beijing University of Chinese Medicine0 sitesTBD
Conditionsinfluenza
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- influenza
- Sponsor
- Beijing University of Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •?1 year old \< age \= 12 years old; ? Meet the diagnostic criteria and syndrome differentiation criteria of influenza; ? Duration of fever \=48 hours; ? The informed consent process is in accordance with the provisions, and the legal representative or the subject child (\=8 years old) signs the informed consent together; ? Novel coronavirus nucleic acid test was negative.
Exclusion Criteria
- •? Diseases with conjunctival pharyngeal fever, herpetic angina, suppurative tonsillitis and novel coronavirus infection that need to be identified with influenza; ? Influenza complications such as sinusitis, otitis media, bronchitis, etc.; ? Severe or critical cases of influenza; ? Antiviral drugs have been used within 48 hours before this visit; ? Positive systemic steroid therapy or other immunosuppressive therapy; ? Have a history of epilepsy or high fever convulsion, recurrent respiratory tract infection; ? Severe malnutrition, rickets children and complicated with heart, brain, liver, kidney and hematopoietic system serious primary diseases; ? to test drug allergy or allergic constitution (to two or more food or drug allergy); ? Other lesions or conditions that reduce the possibility of enrollment or complicate enrollment, such as unstable living environment, inconvenient transportation and other conditions that may easily lead to loss of follow\-up, according to the judgment of the investigator.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 1
A multicenter randomized controlled clinical study of Fuzheng Xiaoji pill in the treatment of metastatic pancreatic cancerPancreatic cancerITMCTR2000003298Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Recruiting
Phase 1
A multicenter randomized controlled clinical study of Qishao Tianxin prescription in the treatment of early urinary incontinence after radical prostatectomy for prostate cancer.rinary incontinenceITMCTR2100004503Beijing Chaoyang Hospital, Capital Medical University
Not yet recruiting
Phase 1
A multicenter randomized controlled clinical study of Chuanhuang prescription combined with reduced glutathione regimen in the treatment of patients with 1-2 grade AKI on the basis of 2-4 stage CKD and its clinical evaluation of early diagnostic markersITMCTR2000003617Shanghai Municipal Hospital of Traditional Chinese Medicine
Not yet recruiting
Not Applicable
A randomized controlled multicenter clinical trial of Xinxinfu combined with Qiangxin Fang in the treatment of coronary heart disease complicated with cardiac insufficiencyITMCTR2000003805Shanghai Municipal Hospital of Traditional Chinese Medicine
Not yet recruiting
Phase 1
A multicenter randomized controlled clinical trial for 'Sanhuangfu Kang Oil' on acute radiation-induced skin lesions in patients with breast cancerBreast cancerITMCTR1900002612The First Affiliated Hospital of Guangzhou University of Traditional Chinese Medicine